Antifungal T cells--progress in manufacture and prospects for the clinic.
Department of Haematology, University of Sydney, Program Director BMT, Head Cell Therapies, Westmead Hospital Sydney, Sydney, Australia. Electronic address: david.gottlieb@sydney.edu.au.
David
D
Gottlieb
D001228:Aspergillosis / Q000628:therapy*; D001232:Aspergillus fumigatus / Q000276:immunology*; D002469:Cell Separation / Q000379:methods*; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods*; D008213:Lymphocyte Activation / Q000276:immunology*; D006377:T-Lymphocytes, Helper-Inducer / Q000637:transplantation*